Skip to main content
SpringerLink
Log in

Autoradiographic analysis of regional alterations in brain receptors following chronic administration and withdrawal of typical and atypical neuroleptics in rats

  • Full Papers
  • Published:
Journal of Neural Transmission / General Section JNT Aims and scope Submit manuscript

Summary

Rats were administered haloperidol, clozapine, raclopride, or no drug for 28 days or 8 months. Following a 3 week withdrawal period, in vitro autoradiography was utilized to examine receptor binding for dopamine D2 ([3H]spiperone and [3H]raclopride), dopamine D1 ([3H]SCH23390), GABAA ([3H]muscimol), benzodiazepine ([3H]RO15-1788), and muscarinic ACh receptors ([3H]QNB). [3H]spiperone was elevated in striatal subregions only in haloperidol-treated rats, with the largest increases seen in the 8 month duration animals. Striatal [3H]raclopride binding was increased after both short- and long-term treatment in both haloperidol and raclopride, but not clozapinetreated animals. Clozapine-treated rats showed significant increases in [3H]SCH23390 in the nucleus accumbens after 28-day administration; otherwise no changes were seen for this ligand in any other groups. Increases in [3H]muscimol binding in the substantia nigra reticulata were seen in haloperidol-treated rats after 8 month treatment. Binding of [3H]QNB and [3H]RO15-1788 were not significantly different from control for any of the drug-treated groups. These data suggest that persisting alterations in receptor binding are primarily seen in dopamine D2 and GABA receptors after withdrawal from chronic administration of haloperidol but not the atypical neuroleptics, clozapine and raclopride.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Allikmets LH, Zarvovsky AM, Nurk AM (1981) Changes in catalepsy and receptor sensitivity following chronic neuroleptic treatment. Eur J Pharmacol 75: 145–147

    Google Scholar 

  • Altar CA, Wasley AM, Neale RF, Stone GA (1986) Typical and atypical antipsychotic occupancy of D2 and S2 receptors: an autoradiographic analysis in rat brain. Brain Res Bull 16: 517–525

    Google Scholar 

  • Altar CA, Boyar WC, Wasley A, Gerhardt SC, Liebman JM, Wood PL (1988) Dopamine neurochemical profile of atypical antipsychotics resembles that of D-1 antagonists. Naunyn Schmiedebergs Arch Pharmacol 338: 162–168

    Google Scholar 

  • Andersen PH, Nielsen EB, Gronvald FC, Braestrup C (1986) Some atypical neuroleptics inhibit [3H]SCH23390 binding in vivo. Eur J Pharmacol 120: 143–144

    Google Scholar 

  • Battaglia G, Titeler M (1982) [3H]N-propylapomorphine and [3H]spiperone binding in brain indicate two states of the D2 dopamine receptor. Eur J Pharmacol 81: 493–498

    Google Scholar 

  • Boyson SJ, McGonigle P, Luthin GR, Wolfe BB, Molinoff PB (1988) Effects of chronic administration of neuroleptic and anticholinergic agents on densities of D2 dopamine and muscarinic cholinergic receptors in rat striatum. J Pharmacol Exp Ther 244: 987–993

    Google Scholar 

  • Burt DR, Creese I, Snyder SH (1977) Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. Science 196: 326–328

    Google Scholar 

  • Chipkin RE, McQuade RD, Iorio LC (1987) D1 and D2 dopamine binding site upregulation and apomorphine-induced stereotypy. Pharmacol Biochem Behav 28: 477–482

    Google Scholar 

  • Creese I, Chen A (1985) Selective D-1 dopamine receptor increase following chronic treatment with SCH23390. Eur J Pharmacol 109: 127–128

    Google Scholar 

  • Dawson TM, Gehlert DR, McCabe RT, Barnett A, Wamsley JK (1986) D-1 dopamine receptors in the rat brain: a quantitative autoradiographic analysis. J Neurosci 6 (8): 2352–2365

    Google Scholar 

  • Farde L, Wiesel FA, Halldin C, Sedvall G (1988) Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. Arch Gen Psychiatry 45: 71–76

    Google Scholar 

  • Fibiger HC, Lloyd KG (1984) Neurobiological substrates of tardive dyskinesia: the GABA hypothesis. Trends Neurosci 7: 462–464

    Google Scholar 

  • Fowler CJ, Magnusson O, Thorell G, Mohringe B, Huang RB (1987) Dopamine turnover and glutamate decarboxylase activity in the rat brain after acute and chronic treatment with raclopride, a dopamine D2-selective antagonist. Neuropharmacology 26 (4): 339–345

    Google Scholar 

  • Frey JM, Ticku MJ, Huffman RD (1987) GABAergic supersensitivity within the pars reticulata of the rat substantia nigra following chronic haloperidol administration. Brain Res 425: 73–84

    Google Scholar 

  • Friedman E, Gianutsos G, Kuster J (1983) Chronic fluphenazine and clozapine elicit opposite changes in brain muscarinic receptor binding: implications for understanding tardive dyskinesia. J Pharmacol Exp Ther 226: 7–12

    Google Scholar 

  • Gale K (1980) Chronic blockade of dopamine receptors by anti-schizophrenic drugs enhances GABA binding in substantia nigra. Nature 283: 569–570

    Google Scholar 

  • Gale K, Casu M (1981) Dynamic utilization of GABA in substantia nigra: regulation by dopamine and GABA in the striatum, and its clinical and behavioral implications. Mol Cell Biochem 39: 369–405

    Google Scholar 

  • Gavish M, Weizman Becker D, Tanne Z (1988) Effect of chronic haloperidol treatment on peripheral benzodiazepine binding sites in cerebral cortex of rats. J Neural Transm 74: 109–116

    Google Scholar 

  • Geary WA, Toga AW, Wooten GF (1985) Quantitative film autoradiography for tritium: methodological considerations. Brain Res 337: 99–108

    Google Scholar 

  • Goeders NE, Kuhar MJ (1985) Benzodiazepine receptor binding in vivo with [3H]RO15-1788. Life Sci 37: 345–355

    Google Scholar 

  • Hall H, Sallemark M (1987) Effects of chronic neuroleptic treatment on agonist affinity states of the dopamine-D2 receptor in the rat brain. Pharmacol Toxicol 60: 359–363

    Google Scholar 

  • Hauser D, Closse A (1978) [3H]-Clozapine binding to rat brain membranes. Life Sci 23: 557–562

    Google Scholar 

  • Hess EJ, Norman AB, Creese I (1988) Chronic treatment with dopamine receptor antagonists, behavioral and pharmacological effects on D1 and D2 dopamine receptors. J Neurosci 8: 2361–2370

    Google Scholar 

  • Huffman RD, Ticku MJ (1983) The effects of chronic haloperidol administration on GABA receptor binding. Pharmacol Biochem Behav 19: 199–204

    Google Scholar 

  • Hyttel J (1986) Effect of prolonged treatment with neuroleptics on dopamine D-1 and D-2 receptor density in corpus striatum of mice. Acta Pharmacol Toxicol 59: 387–391

    Google Scholar 

  • Jenner P, Rupniak NMJ, Marsden CD (1985) Differential alteration of striatal D-1 and D-2 receptors induced by the long-term administration of haloperidol, sulpiride or clozapine to rats. In: Casey DE, Chase TN, Christensen AV, Gerlach J (eds) Dyskinesia — research and treatment. Springer, Berlin Heidelberg New York Tokyo, pp 174–181

    Google Scholar 

  • Jenner P, Marsden CD (1987) Chronic pharmacological manipulation of dopamine receptors in brain. Neuropharmacology 26: 931–940

    Google Scholar 

  • Jeste DV, Wyatt RJW (1982) Therapeutic strategies against tardive dyskinesia: two decades of experience. Arch Gen Psychiatry 39: 803–816

    Google Scholar 

  • Kohler C, Ogren SO, Haglund L, Angeby T (1979) Regional displacement by sulpiride of [3H]spiperone binding in vivo. Biochemical and behavioural evidence for a preferential action on limbic and nigral dopamine receptors. Neurosci Lett 13: 51–56

    Google Scholar 

  • Kohler C, Radesater AC (1986) Autoradiographic visualization of dopamine D-2 receptors in the monkey brain using the selective benzamide drug [3H]raclopride. Neurosci Lett 66: 85–90

    Google Scholar 

  • Koller WC (1984) Effects of intermittent haloperidol treatment on dopamine receptor sensitivity in guinea pigs. Psychopharmacology 84: 98–100

    Google Scholar 

  • Konig JFR, Klippel RA (1963) The rat brain: a stereotaxic atlas of the forebrain and lower parts of the brain stem. Krieger, New York

    Google Scholar 

  • Marsden CD, Jenner P (1980) The pathophysiology of extrapyramidal side effects of neuroleptic drugs. Psychol Med 10: 55–72

    Google Scholar 

  • McGonigle P, Boyson SJ, Reuter S, Molinoff PB (1989) Effects of chronic treatment with selective and nonselective antagonists on the subtypes of dopamine receptors. Synapse 3: 74–82

    Google Scholar 

  • Memo M, Lucchi L, Spano PF, Trabucchi M (1980) Aging process affects a single class of dopamine receptors. Brain Res 202: 488–492

    Google Scholar 

  • Memo M, Pizzi M, Missale C, Carruba MO, Spano P (1987) Modification of the function of D1 and D2 dopamine receptors in striatum and nucleus accumbens of rats chronically treated with haloperidol. Neuropharmacology 26 (5): 477–480

    Google Scholar 

  • Misra CH, Shelat H, Smith RC (1981) Influence of age on the effects of chronic fluphenazine on receptor binding in rat brain. Eur J Pharmacol 76: 317–324

    Google Scholar 

  • Muller P, Seeman P (1977) Brain neurotransmitter receptors after long-term haloperidol: dopamine, acetylcholine, serotonin, α-noradrenergic and naloxone receptors. Life Sci 21: 1751–1758

    Google Scholar 

  • Muller P, Seeman P (1978) Dopaminergic supersensitivity after neuroleptics: time-course and specificity. Psychopharmacology 60: 1–11

    Google Scholar 

  • Murugaiah K, Fleminger S, Theodorou A, Jenner P, Marsden CD (1983) Persistent increase in striatal dopamine stimulated adenylate cyclase activity persists for more than six months but disappears after 1 year following withdrawal from 18 months cis-flupenthixol intake. Biochem Pharmacol 32: 2495–2499

    Google Scholar 

  • Murugaiah K, Theodorou A, Clow A, Jenner P, Marsden CD (1985) Effects of discontinuous drug administration on the development of dopamine receptor supersensitivity during chronic trifluoperazine or cis-flupenthixol administration to rats. Psychpharmacology 86: 228–232

    Google Scholar 

  • Ogren SV, Hall H, Kohler C, Magnusson O, Sjostrand SE (1986) The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions. Psychopharmacology 90: 287–294

    Google Scholar 

  • Olsen RW, Ticku MK, Van Ness PC, Greenlee D (1978) Effects of drugs on γ-aminobutyric acid receptors, uptake, release and synthesis in vitro. Brain Res 139: 277–294

    Google Scholar 

  • Owen F, Cross AJ, Waddington JL, Poulter M, Gamble SJ, Crow TJ (1980) Dopamine-mediated behaviour and3H-spiperone binding to striatal membranes in rats after nine months haloperidol administration. Life Sci 26 (1): 55–59

    Google Scholar 

  • Palacios JM, Niehoff DL, Kuhar MH (1981a) [3H]spiperone binding sites in brain: autoradiographic localization of multiple receptors. Brain Res 213: 277–289

    Google Scholar 

  • Palacios JM, Wamsley JK, Kuhar MH (1981b) High affinity GABA receptors — autoradiographic localization. Brain Res 222: 285–307

    Google Scholar 

  • Randall PK, Severson JA, Hurd SM, McClure WO (1985) Effect of duration of haloperidol treatment on DA receptor supersensitization in aging C57BL/6J mice. Brain Res 333: 85–95

    Google Scholar 

  • Rupniak NMJ, Jenner P, Marsden CD (1983) The effect of chronic neuroleptic administration on cerebral dopamine receptor function. Life Sci 32: 2289–2311

    Google Scholar 

  • Rupniak NMJ, Kilpatrick G, Hall MD, Jenner P, Marsden CD (1984a) Differential alterations in striatal dopamine receptor sensitivity induced by repeated admininistration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats. Psychopharmacology 84: 512–519

    Google Scholar 

  • Rupniak NMJ, Mann S, Hall MD, Fleminger S, Kilpatrick G, Jenner P, Marsden CD (1984b) Differential effects of continuous administration for 1 year of haloperidol of sulpiride on striatal dopamine function in the rat. Psychopharmacology 84: 503–511

    Google Scholar 

  • Rupniak NMJ, Mann S, Hall MD, Fleminger S, Kilpatrick G, Jenner P, Marsden CD (1985) Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat. Biochem Pharmacol 34 (15): 2755–2763

    Google Scholar 

  • Rupniak NMJ, Briggs RS, Peterson MM, Mann S, Reavill C, Jenner P, Marsden CD (1986) Differential alterations in striatal function in rats during 12 months continuous administration of haloperidol, sulpiride, or clozapine. Clin Neuropharmacol 9 (3): 282–292

    Google Scholar 

  • Rupniak NMJ, Prestwich SA, Horton RW, Jenner P, Marsden CD (1987) Alterations in cerebral glutamic acid decarboxylase and [3H]-flunitrazepam binding during continuous treatment of rats for up to 1 year with haloperidol, sulpiride or clozapine. J Neural Transm 68: 113–125

    Google Scholar 

  • Satoh H, Kuwaki T, Shirakawa K, Kohjimoto Y, Ono T, Shibayama F, Nomura Y (1987) Effect of long-term dosing with tiapride on brain dopamine receptors and metabolism in rats. Comparative study with sulpiride and haloperidol. Jpn J Pharmacol 44: 393–404

    Google Scholar 

  • Savasta M, Dubois A, Scatton B (1986) Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SCH23390. Brain Res 375: 291–301

    Google Scholar 

  • Scheel-Kruger J (1986) Dopamine-GABA interactions: evidence that GABA transmits, modulates and mediates dopaminergic functions in the basal ganglia and the limbic system. Acta Neurol Scand [Suppl 107] 73: 1–54

    Google Scholar 

  • See RE, Aravagiri M, Ellison GD (1989) Chronic neuroleptic treatment in rats produces persisting changes in GABAA and dopamine D-2, but not dopamine D-1 receptors. Life Sci 44 (3): 229–236

    Google Scholar 

  • See RE, Ellison G (1990a) Intermittent and continuous haloperidol regimens produce different types of oral dyskinesias in rats. Psychopharmacology 100: 404–412

    Google Scholar 

  • See RE, Ellison G (1990b) Comparison of chronic administration of haloperidol and the atypical neuroleptics, clozapine and raclopride, in an animal model of tardive dyskinesia. Eur J Pharmacol (in press)

  • See RE (1989) The effects of chronic neuroleptic administration on motor behavior and brain receptors in an animal model of tardive dyskinesia. Doctoral dissertation, University Microfilms International, Michigan

    Google Scholar 

  • Seeger TF, Thal L, Gardner EL (1982) Behavioral and biochemical aspects of neurolepticinduced dopaminergic supersensitivity: studies with chronic clozapine and haloperidol. Psychopharmacology 76: 182–187

    Google Scholar 

  • Seeman P (1987) Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1: 133–152

    Google Scholar 

  • Tamminga CA, Gerlach J (1987) New neuroleptics and experimental antipsychotics in schizophrenia. In: Meltzer HY (ed) Psychopharmacology — the third generation of progress. Raven, New York, pp 1129–1140

    Google Scholar 

  • Theodorou A, Hall MD, Jenner P, Marsden CD (1980) Cation regulation differentiates specific binding of [3H]sulpiride and [3H]spiperone to rat striatal preparations. J Pharm Pharmacol 32: 441–444

    Google Scholar 

  • Toga AW, Santori EM, Samaie M (1986) Regional distribution of flunitrazepam binding constants: visualizing Kd and Bmax by digital image analysis. J Neurosci 6 (9): 2747–2756

    Google Scholar 

  • Wamsley JK, Lewis MS, Young WS, Kuhar MJ (1981) Autoradiographic localization of muscarinic cholinergic receptors in rat brainstem. J Neurosci 1 (2): 176–191

    Google Scholar 

  • Wamsley JK, Gehlert DR, Olsen RW (1986) The benzodiazepine/barbiturate-sensitive convulsant/GABA receptor/chloride ionophore complex: autoradiographic localization of individual components. In: Olsen RW, Venter JC (eds) Benzodiazepine/GABA receptors and chloride channels: structural and functional properties. Liss, New York, pp 299–313

    Google Scholar 

  • Zahniser NR, Dubocovich ML (1983) Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum. J Pharmacol Exp Ther 227: 592–599

    Google Scholar 

Download references

Author information

Author notes

  1. R. E. See

    Present address: Department of Psychology, School of Medicine, University of California, Los Angeles, CA, USA

Authors and Affiliations

  1. Department of Psychology, School of Medicine, University of California, Los Angeles, CA, USA

    G. Ellison

  2. Laboratory of Neuro Imaging, Department of Neurology, School of Medicine, University of California, Los Angeles, CA, USA

    A. W. Toga

Authors
  1. R. E. See
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. W. Toga
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Ellison
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

See, R.E., Toga, A.W. & Ellison, G. Autoradiographic analysis of regional alterations in brain receptors following chronic administration and withdrawal of typical and atypical neuroleptics in rats. J. Neural Transmission 82, 93–109 (1990). https://doi.org/10.1007/BF01245166

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01245166

Keywords

Search

Navigation